“The Key players in the Stem Cell Assays Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Promega ...

Life Technologies signed a research and license agreement with Harvard University under which the firm has acquired exclusive rights to develop a panel of characterization assays designed to rapidly ...

Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular ...

In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...

The Europe stem cell assay market is expected to grow $793 million by 2025. The market growth is expected at the CAGR of 21.49% in the forecast period. The base year considered for the market study is ...

Keeping Cells “Happy” and Healthy Helps Support Complex Multiplexed Assays Maintaining cell viability throughout the cell culture process is virtually a nonissue in current drug discovery efforts. But ...

Straits Research released its highly anticipated report, “Global Stem Cell Assays Market Size & Outlook, 2026-2034”. According to this study, the market size is valued at USD 3.28 billion in 2025 and ...

The primary causes of disability and mortality in the US are chronic diseases such as cancer, neurodegenerative disorders, cardiovascular disease, obesity, arthritis, and diabetes. The increase in ...

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

This article is based on a poster originally authored by Blaise Louis, Serena Belluschi, Daniel Weekes, Tom Mitchell, Holly Herbert, Tarun Vemulkar and Jeroen Verheyen, which was presented at ELRIG ...